Edge Total Intelligence Inc. (CTRL.V)
CAD 0.69
(23.21%)
CAD 0.69
(23.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -967.53 Thousand | -4.86 Million | -1.23 Million | -91.24 Thousand | -15.95 Thousand |
| Net Income | -1.63 Million | -8.11 Million | -10.6 Million | -100.13 Thousand | -37.52 Thousand |
| Depreciation & Amortization | 1.07 Million | 1.46 Million | 1.45 Million | 749.24 Thousand | - |
| Deferred income taxes | - | -4.22 Million | - | - | - |
| Stock-based compensation | 472.5 Thousand | 269.25 Thousand | - | - | 4888.73 |
| Change in working capital | -714.49 Thousand | -980.36 Thousand | 1.98 Million | 8882.81 | 16.67 Thousand |
| Other non-cash items | 1.58 Million | 6.72 Million | 5.92 Million | - | 0.96 |
| Investing Cash Flow | - | -333.85 Thousand | -876.24 Thousand | -1.52 Million | - |
| Investments in PPE | 2.55 | -333.85 Thousand | -876.24 Thousand | -6454.99 | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | -324.08 Thousand | -1.08 Million | -1.52 Million | - |
| Financing Cash Flow | 1.31 Million | 884.2 Thousand | 5.79 Million | 126.41 Thousand | 36.86 Thousand |
| Debt repayment | -1.41 Million | -963.37 Thousand | -925.06 Thousand | -433.89 Thousand | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 24.65 Thousand | 25.43 Thousand | 4.31 Million | 156.84 Thousand | 76.55 Thousand |
| Other Financing Activities | 5.38 Million | -104.6 Thousand | 2.4 Million | -30.42 Thousand | -39.68 Thousand |
| Accounts receivables | 897.33 Thousand | -1.03 Million | 1.66 Million | 304.05 Thousand | - |
| Accounts payables | -24.6 Thousand | -173.19 Thousand | 782.4 Thousand | - | - |
| Inventory | - | 173.19 Thousand | -1.66 Million | - | - |
| Other working capital | -1.58 Million | 51.3 Thousand | 1.2 Million | 8882.81 | 16.67 Thousand |
| Cash at beginning of period | 650.55 Thousand | 4.79 Million | 110.03 Thousand | 21.42 Thousand | - |
| Cash at end of period | 1.3 Million | 650.55 Thousand | 3.79 Million | 56.58 Thousand | 20.91 Thousand |
| Capital Expenditure | 2.55 | -333.85 Thousand | -876.24 Thousand | -6454.99 | - |
| Effect of forex changes on cash | 257.72 Thousand | 172.27 Thousand | - | - | - |
| Net cash flow / Change in cash | 659.18 Thousand | -4.13 Million | 3.68 Million | 35.16 Thousand | 20.91 Thousand |
| Free Cash Flow | -967.52 Thousand | -5.19 Million | -2.11 Million | -97.7 Thousand | -15.95 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -352.43 Thousand | -2.27 Million | -1.63 Million | -884.39 Thousand | 1.11 Million | -852.04 Thousand |
| Depreciation & Amortization | 5445.00 | 276.75 Thousand | 1.07 Million | 708.42 Thousand | -82.41 Thousand | -178.15 Thousand |
| Deferred income taxes | - | - | - | - | -59.33 Thousand | 178.15 Thousand |
| Stock-based compensation | 130.39 Thousand | - | 472.5 Thousand | 472.5 Thousand | -6907.00 | -115.17 Thousand |
| Change in working capital | 420.55 Thousand | 396.93 Thousand | -714.49 Thousand | -391.6 Thousand | -487.67 Thousand | 106.14 Thousand |
| Other non-cash items | 72.07 Thousand | 1.86 Million | 1.58 Million | 958.58 Thousand | -68.64 Thousand | 288.78 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -26.8 Thousand | -17.92 Thousand | 1.31 Million | 997.23 Thousand | -54.43 Thousand | -874.61 Thousand |
| Debt repayment | -27.01 Thousand | - | -1.41 Million | -978.97 Thousand | -7776.00 | -3 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 9796.20 | 24.65 Thousand | 24.65 Thousand | -19.77 Thousand | -69.64 |
| Other Financing Activities | 205.00 | - | 5.38 Million | - | -46.66 Thousand | 2.12 Million |
| Accounts receivables | 109.71 Thousand | -78.86 Thousand | 897.33 Thousand | -378.23 Thousand | 1.41 Million | -696.35 Thousand |
| Accounts payables | - | -187.4 Thousand | -24.6 Thousand | - | 45.82 Thousand | -44.14 Thousand |
| Inventory | - | - | - | - | -1.41 Million | - |
| Other working capital | 146.42 Thousand | 663.2 Thousand | -1.58 Million | 157.29 Thousand | -533.5 Thousand | 802.5 Thousand |
| Cash at beginning of period | 586.7 Thousand | 1.3 Million | 650.55 Thousand | 185.6 Thousand | 527.97 Thousand | 1.22 Million |
| Cash at end of period | 341.95 Thousand | 793.96 Thousand | 1.3 Million | 993.28 Thousand | 185.6 Thousand | 527.97 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 8060.00 | - | 257.72 Thousand | - | - | - |
| Net cash flow / Change in cash | -244.74 Thousand | -515.78 Thousand | 659.18 Thousand | 807.67 Thousand | -342.36 Thousand | -699.53 Thousand |
| Free Cash Flow | -226 Thousand | -550.2 Thousand | -967.53 Thousand | -399.44 Thousand | 411.6 Thousand | -572.28 Thousand |
GR1T
TFCILTD
MMM
VPLM
JUBLPHARMA
300220